Zanubrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Update Venetoclax in CLL
Patient Power
Cancer.gov
NCCN Guidelines for Patients for CLL
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic